NHMRC funding success at the Monash Health Translation Precinct

Dr David Scott

Monash Health Translation Precinct (MHTP) researchers from the School of Clinical Sciences at Monash Health (SCS) and Hudson Institute of Medical Research have been successful in the latest round of NHMRC grants.

Publications week ending 31 August 2018

MANAGEMENT OF ENDOCRINE DISEASE: Therapeutics of Vitamin D. Peter Ebeling et al. published in the European Journal of Endocrinology.

Heritable methylation marks associated with breast and prostate cancer risk. Melissa Southey et al. published in The Prostate.

Interprofessional education and practice guide No. 9: Sustaining interprofessional simulation using change management principles. Arunaz Kumar et al. published in The Journal of Interprofessional Care.

Behavioral and neurodevelopmental outcome of children after maternal allopurinol administration during suspected fetal hypoxia: 5-year follow up of the ALLO-trial. Ben Mol et al. published in PLoS One.

Publications for week ending 24 June 2018

Chimeric antigen receptor T (CAR T) cells: another cancer therapy with potential applications in kidney disease and transplantation Richard Kitching, Julie Jaw published in Kidney International.

Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysis 
Helena Teede et al. published in Systematic Reviews.

Spontaneous and iatrogenic preterm birth rates among unselected women in three consecutive pregnancies

Ben Mol et al. published in the European Journal of Obstetrics, Gynecology, and Reproductive Biology.

Ovarian stimulation in infertile women treated with the use of intrauterine insemination: a cohort study from China

Ben Mol et al. published in Fertility and Sterility.

The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial

Ben Mol et al. published in BMC Women's Health. 

Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study)

Ben Mol et al. published in Hypertension.

Treatment strategies and cumulative live birth rates in WHO-II ovulation disorders

Ben Mol et al. published in the European Journal of Obstetrics, Gynecology and Reproductive Biology. 

Pessary for preterm birth prevention in twin pregnancy with short cervix: 3-year follow-up study

Ben Mol et al. published in Ultrasound in Obstetrics & Gynecology.

Read article here.

Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction

Ben Mol et al. published in Human Reproduction.

Read article here.

The prognostic capacity of transvaginal hydrolaparoscopy to predict non-IVF conception

Ben Mol et al. published in Reproductive Biomedicine Online.

Read article here.

World-renowned obstetrician and gynaecologist joins MHTP

Professor Ben Mol

The Monash Health Translation Precinct (MHTP) welcomes Ben (Willem) Mol, who started last week as Professor of Obstetrics and Gynaecology at Monash University and as Consultant Obstetrics and Gynaecology at Monash Health.  

Professor Mol’s research is focused on the organisation of multi-centric evaluative research in Obstetrics, Gynaecology and Fertility.

“My research is focused mainly upon everyday practices—my most important task is the stimulation and innovation of evaluative research in obstetrics, gynaecology and reproductive medicine,” Professor Mol said.

After studying medicine at the University of Amsterdam, Professor Mol worked in the Department of Clinical Epidemiology and Biostatistics at the Academic Medical Centre, Amsterdam (AMC). In 1999 he obtained his doctorate with honours at the Faculty of Medicine, University of Amsterdam with his dissertation entitled Evaluating the effectiveness of diagnostic tests: tubal subfertility and ectopic pregnancy. 

Professor Mol trained as a gynaecologist at the University Medical Centre (Universitair Medisch Centrum) in Utrecht and from 2002 he was a senior researcher in the department of Obstetrics and Gynaecology at the AMC. From 2003 to 2007, he worked as a gynaecologist-perinatologist at the Maxima Medisch Centrum, in Eindhoven, and between 2007-2013 as Professor of Obstetrics and Gynaecology at the AMC in Amsterdam. 

Professor Mol was instrumental in initiating the Dutch consortium for Research in Women’s Health, in which 70 hospitals collaborate in multicentre trials.  Main topics that were evaluated were timing and methods of induction of labour, prevention of preterm birth with pessary, tocolysis, indications for IVF, tubal flushing for infertility and treatment of menorrhagia.

He has worked at the University of Adelaide since 2014, and holds an NHMRC practitioner fellowship, which was awarded as the highest ranked application in 2014. During his time in Adelaide, Professor Mol developed extensive relations with Asian universities.

“I am delighted to be starting my appointment at Monash University and Monash Health,” Professor Mol said.

“My ambitions at Monash are to translate the findings of clinical practice, to initiate a Victorian clinical trial network in women’s health research, to extend my global collaborations and to mentor junior colleagues in these ambitions.”

Professor Mol’s professional adage is ‘A day without randomisation is a day without progress'.